vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and ARCBEST CORP (ARCB). Click either name above to swap in a different company.
ARCBEST CORP is the larger business by last-quarter revenue ($998.8M vs $829.0M, roughly 1.2× Acadia Healthcare Company, Inc.). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs -0.1%, a 0.6% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 3.3%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -3.7%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
ArcBest Corporation is a leading U.S.-based logistics and transportation solutions provider. It offers end-to-end supply chain services including less-than-truckload freight shipping, full truckload services, warehousing, expedited delivery, and customized logistics consulting, serving enterprise, small business, and government clients across North America and select global markets.
ACHC vs ARCB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $998.8M |
| Net Profit | $4.5M | $-1.0M |
| Gross Margin | — | — |
| Operating Margin | — | 0.3% |
| Net Margin | 0.5% | -0.1% |
| Revenue YoY | 7.5% | 3.3% |
| Net Profit YoY | -50.8% | -133.1% |
| EPS (diluted) | $0.05 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $998.8M | ||
| Q4 25 | $821.5M | $972.7M | ||
| Q3 25 | $851.6M | $1.0B | ||
| Q2 25 | $869.2M | $1.0B | ||
| Q1 25 | $770.5M | $967.1M | ||
| Q4 24 | $774.2M | $1.0B | ||
| Q3 24 | $815.6M | $1.1B | ||
| Q2 24 | $796.0M | $1.1B |
| Q1 26 | $4.5M | $-1.0M | ||
| Q4 25 | $-1.2B | $-8.1M | ||
| Q3 25 | $36.2M | $39.3M | ||
| Q2 25 | $30.1M | $25.8M | ||
| Q1 25 | $8.4M | $3.1M | ||
| Q4 24 | $32.6M | $29.0M | ||
| Q3 24 | $68.1M | $100.3M | ||
| Q2 24 | $78.5M | $46.9M |
| Q1 26 | — | 0.3% | ||
| Q4 25 | -142.4% | -0.8% | ||
| Q3 25 | 4.7% | 5.2% | ||
| Q2 25 | 5.8% | 3.6% | ||
| Q1 25 | 1.7% | 0.7% | ||
| Q4 24 | 4.9% | 3.8% | ||
| Q3 24 | 12.1% | 12.7% | ||
| Q2 24 | 13.4% | 4.5% |
| Q1 26 | 0.5% | -0.1% | ||
| Q4 25 | -143.3% | -0.8% | ||
| Q3 25 | 4.3% | 3.7% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 1.1% | 0.3% | ||
| Q4 24 | 4.2% | 2.9% | ||
| Q3 24 | 8.4% | 9.4% | ||
| Q2 24 | 9.9% | 4.4% |
| Q1 26 | $0.05 | $-0.05 | ||
| Q4 25 | $-12.98 | $-0.35 | ||
| Q3 25 | $0.40 | $1.72 | ||
| Q2 25 | $0.33 | $1.12 | ||
| Q1 25 | $0.09 | $0.13 | ||
| Q4 24 | $0.36 | $1.21 | ||
| Q3 24 | $0.74 | $4.23 | ||
| Q2 24 | $0.85 | $1.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $86.4M |
| Total DebtLower is stronger | $2.5B | $223.7M |
| Stockholders' EquityBook value | $2.0B | $1.3B |
| Total Assets | $5.5B | $2.5B |
| Debt / EquityLower = less leverage | 1.29× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $86.4M | ||
| Q4 25 | $133.2M | $124.2M | ||
| Q3 25 | $118.7M | $132.6M | ||
| Q2 25 | $131.4M | $139.7M | ||
| Q1 25 | $91.2M | $98.7M | ||
| Q4 24 | $76.3M | $157.2M | ||
| Q3 24 | $82.1M | $191.1M | ||
| Q2 24 | $77.2M | $260.5M |
| Q1 26 | $2.5B | $223.7M | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $214.1M | ||
| Q2 25 | $2.3B | $241.4M | ||
| Q1 25 | $2.2B | $214.2M | ||
| Q4 24 | $2.0B | $189.1M | ||
| Q3 24 | $1.9B | $180.5M | ||
| Q2 24 | $1.8B | $203.6M |
| Q1 26 | $2.0B | $1.3B | ||
| Q4 25 | $1.9B | $1.3B | ||
| Q3 25 | $3.1B | $1.3B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $3.1B | $1.3B | ||
| Q3 24 | $3.0B | $1.3B | ||
| Q2 24 | $3.0B | $1.2B |
| Q1 26 | $5.5B | $2.5B | ||
| Q4 25 | $5.5B | $2.5B | ||
| Q3 25 | $6.4B | $2.5B | ||
| Q2 25 | $6.3B | $2.5B | ||
| Q1 25 | $6.1B | $2.4B | ||
| Q4 24 | $6.0B | $2.4B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $5.7B | $2.4B |
| Q1 26 | 1.29× | 0.17× | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 0.16× | ||
| Q2 25 | 0.74× | 0.19× | ||
| Q1 25 | 0.72× | 0.17× | ||
| Q4 24 | 0.64× | 0.14× | ||
| Q3 24 | 0.62× | 0.14× | ||
| Q2 24 | 0.62× | 0.17× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $44.7M | ||
| Q3 25 | $73.2M | $98.2M | ||
| Q2 25 | $133.5M | $108.4M | ||
| Q1 25 | $11.5M | $-22.3M | ||
| Q4 24 | $116.7M | $56.8M | ||
| Q3 24 | $163.1M | $88.8M | ||
| Q2 24 | $171.1M | $133.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $36.9M | ||
| Q3 25 | $-63.0M | $33.2M | ||
| Q2 25 | $-34.2M | $80.9M | ||
| Q1 25 | $-163.2M | $-36.8M | ||
| Q4 24 | $-86.8M | $3.5M | ||
| Q3 24 | $-27.1M | $23.9M | ||
| Q2 24 | $16.9M | $83.9M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 3.8% | ||
| Q3 25 | -7.4% | 3.2% | ||
| Q2 25 | -3.9% | 7.9% | ||
| Q1 25 | -21.2% | -3.8% | ||
| Q4 24 | -11.2% | 0.4% | ||
| Q3 24 | -3.3% | 2.2% | ||
| Q2 24 | 2.1% | 7.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.8% | ||
| Q3 25 | 16.0% | 6.2% | ||
| Q2 25 | 19.3% | 2.7% | ||
| Q1 25 | 22.7% | 1.5% | ||
| Q4 24 | 26.3% | 5.3% | ||
| Q3 24 | 23.3% | 6.1% | ||
| Q2 24 | 19.4% | 4.6% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 2.50× | ||
| Q2 25 | 4.43× | 4.20× | ||
| Q1 25 | 1.37× | -7.13× | ||
| Q4 24 | 3.58× | 1.96× | ||
| Q3 24 | 2.39× | 0.89× | ||
| Q2 24 | 2.18× | 2.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ARCB
Segment breakdown not available.
